The collaboration is directly aimed at improving Quest Diagnostics' core services in diagnostics, which is likely to enhance its market position and appeal to investors by potentially increasing its service demand and efficiency. This strategic move could be seen positively by the market, reflecting in a short-term positive impact on its stock price.